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The  mechanism  by  which  self tolerance  is  achieved  is  little  understood.  Until 
recently,  it  was  assumed  that  in  normal  individuals  lymphocyte reactions  against 
components of self did  not  occur.  TOlerance of this  kind was assumed  to be based 
partly on the irreversible loss of lymphocytes directed against accessible self antigens, 
and  partly on  the sequestering of some self antigens  from the  immune system  (1). 
Increasing  evidence  indicates,  however,  that  self tolerance  is  a  far  more  complex 
phenomenon. Lymphocytes recognizing autoantigens without leading to autoimmune 
reactions  have  been  demonstrated  in  many  experiments;  for  example,  in  normal 
humans,  B  cells bind  homologous thyroglobulin  (2,  3)  or DNA  (4),  whereas  in the 
mouse, B lymphocytes recognize distinct erythrocyte autoantigens (5, 6). Furthermore, 
it  has been possible to sensitize T  cells in  vitro against  syngeneic fibroblasts  (7)  or 
autologous  thymus epithelium  cells  (8).  Recently,  two  general  mechanisms  for self 
tolerance have been proposed:  (a)  an unresponsive state that is characterized by an 
irreversible  loss  of competent  T  and  B  lymphocytes  that  is  maintained  by  the 
concentration of self components in the body fluid, and (b) a peripheral inhibition of 
competent lymphocytes by suppressor T  cells and the products of such cells (9). 
We have attempted to approach the question of the regulation of self tolerance by 
examining the  immune response against  autologous  testicular  cells in  a  mixed cell 
response  in  vitro.  We  studied  lymphocyte reactivity  against  germ  cells  which  are 
sequestered from the immune system versus somatic cells which are not sequestered. 
We report here that under in vitro conditions, autologous germ cells are efficient 
inducers of tolerance by evoking suppressor T  cells, whereas autologous somatic cells 
of the testis are immunogenic. 
Materials and Methods 
Animals.  Young adult male mice (8-12 wk of age) were used throughout all studies.  The 
inbred  strains  A/J,  C57BL/6  (B6),  ~ BALB/c,  CBA,  and  AKR  were  purchased  from The 
Jackson Laboratory (Bar Harbor, Maine) or were supplied from the breeding facilities of the 
Sloan-Kettering Institute for Cancer Research, New York. 
The sterile mutants W/W  v were bred in our own mouse colony.  They are F1 mice deriving 
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from the cross C57BL/6J-WV/+ ×  WB/REJ-W/+. Wild-type (+/+) animals of this cross are 
normal and were used as controls. 
Cell Preparations.  Animals providing the responder cells were ether anesthetized and bled. 
The blood was collected and used as a source for autologous serum, which was heat inactivated 
for 30 rain at 56°C. The other animals were killed by cervical dislocation. Spleen cell suspensions 
were prepared in cold phosphate-buffered saline (PBS)  in a loosely fitting glass homogenizer. 
The erythrocytes were lysed by brief hypotonic shock treatment. Testicular cell suspensions 
were  prepared in two different ways:  either by protease treatment or mechanical treatment. 
Sequential enzymatic dissociation was  performed  according to  the  modified  procedure  of 
Romrell et al. (10). The testes were decapsulated, slightly teased apart, and incubated at 37°C 
for  12 min in 0.1% collagenase (Worthington Biochemical Corp., Freehold, N. J.) dissolved in 
PBS. Thorough pipetting denuded the seminiferous tubules and yielded a suspension of free 
extratubular cells (fibroblasts, lymphoid cells, and connective tissue elements) and ~ 15-20% of 
the androgen-secreting  Leydig cells (designated as Tel). The tubular segments were then broken 
up by a  15-min incubation at 37°C in 0.025% trypsin (Grand Island Biological Co.,  Grand 
Island, N. Y.) that was dissolved  in Ca++-ion  - and Mg++-ion-free  PBS, to release germ cells at 
all stages of spermatogenesis and Sertoli cells (designated as TeII). The different cell types were 
identified by light microscopy according to their morphological characteristics (10). 3-6 ×  106 
6  TeI cells  and  18-25  X  10  TeII cells  per mouse were obtained by protease treatment. For 
mechanical dissociation of testicular cells, the decapsulated testes were gently teased apart and 
pipetted several  times in PBS without Ca  ++ and Mg  +÷ plus 0.2 mM EDTA. This treatment 
released mostly interstitial cells. Sertoli cells and germ cells were obtained by homogenizing the 
seminiferous tubules. Mechanical cell dissociation yielded 3-5 ×  10  e TeI cells and only 5-10 
×  106 TeII cells per pair of testes.  Because of the better yield of cells and the more gentle 
treatment, for most of the experiments, testicular cells were obtained by protease treatment, 
unless otherwise stated.  For cultivation, the  single cell suspensions were  washed  once and 
resuspended in RPMI-1640 medium (Grand Island Biological  Co.), supplemented with  1% 
autologous mouse serum and 0.05 mM 2-mercaptoethanol. 
Elimination of Lymphocyte Subclasses.  Suppressor T cells were eliminated by incubation of 40 
X  10  s spleen cells/ml with monoclonal anti-Ly-2.2 (1:200  final dilution) for 30 min at 4°C 
followed  by a  30-rain incubation with selected  rabbit complement at 37°C as described by 
Shen et al. (11). This procedure was repeated once. Cell recovery after anti-Ly-2.2 treatment 
was two-thirds of the initial cell number. Elimination  ofThy-1.2-positive  T cells was performed 
twice with monoclonal antibody against Thy-l.2 antigen. 35 ×  106 spleen cells/ml were treated 
with the antibody (1:200 final dilution) according to the procedure described above. Stimulation 
with  phytohemagglutinin (PHA)  after  anti-Thy-l.2 plus complement treatment showed  a 
reduction of the mitogenic response by ~91%. (The monoclonal anti-Ly-2.2 antibody and the 
monoclonal anti-Thy-1.2 antibody were a gift of Dr. U. Hiimmerling, Sloan-Kettering  Institute 
for Cancer Research.)  The elimination  of adherent macrophages and B cells was carried out by 
passing spleen cells over a  nylon-wool column according to the method of Julius et al.  (12). 
After elimination procedures, the cell numbers were readjusted to standard concentrations. 
In Vitro Cultures.  5 ×  105 responder lymphocytes were cultivated in flat-bottomed microtiter 
plates (Fisher Scientific Co., Pittsburgh, Pa.) with either 5 ×  105 irradiated spleen cells (2,000 
rad) or 2 X 105 testicular cells as stimulators in a total vol of 200 #1. The plates were kept in a 
humidified atmosphere of 7% CO2 in air in a 37°C incubator. After 4 d of cultivation, 20 #1 of 
[3H]thymidine solution (50 #Ci/ml  [aH]thymidine; 0.5  #mol  cold  thymidine in  PBS)  was 
added;  16 h  later, the labeled cultures were harvested in a  Titertek multiple cell  harvester 
(Flow Laboratories, Inc., Rockville, Md.)  and the radioactivity was determined in a  liquid 
scintillation  counter (Packard Instrument Co., Inc., Downers Grove, Ill.). The mean values and 
the standard deviations were estimated from five replicate cultures. 
For  mitogenic stimulation, 2  ×  105  spleen cells/well were  cultivated in presence of 0.1 
mitogenic U  of PHA (Burroughs-Wellcome & Co., Research Triangle Park, N. C.)  in a  total 
vol of 200 #1 for 3 d, labeled with [ZH]thymidine, and harvested 4 h later. 
The stimulation index was determined by the following calculation: 
counts per minute of the mean of the experimental group 
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Fro.  1.  Dose-response of normal B6 spleen cells tested against increasing concentrations of autol- 
ognus testicular cells  (TeI O---O;  TeII 0--0)  and autologous spleen cells O-.-O,  and against 
allogeneie testicular cells  (TeI A---A; TeII A--A). The bar indicates stimulation by allogeneic 
spleen cells  (5 ×  10S/well). The 0  represents background incorporation without stimulators. The 
3H-thymidine incorporation values are expressed as counts per minute ±  standard deviations. 
Results 
Dose-Response against Autologous and Allogeneic Testicular Cells.  We were interested in 
lymphocyte reactivity against the immunologically privileged testicular germ cells, on 
the assumption that they would provide an interesting model for studying immune 
reactions against autologous antigens. To obtain these cells, testis cells were fraction- 
ated into two subpopulations: (a) fraction TeII, that contained mostly germ cells and 
Sertoli cells, and  (b) fraction TeI, that contained an enriched population of Leydig 
and  other  interstitial  cells  and  some  contaminating  germ  cells.  We  intended  to 
concentrate  preferentially on  germ  cells  and  to  use  the  TeI  fraction  as  the  most 
appropriate controls. 
The effect of both fractions of autologous and allogeneic testicular cells was tested 
on splenic lymphocyte proliferation in vitro and determined by [nH]thymidine uptake 
after 5 d of cultivation. The proliferative response against autologous TeII fraction is 
shown  in  Fig.  1.  Lymphocyte reactivity  against  this  fraction  was  very  low.  No 
significant  lymphocyte proliferation  over background  level  was  observed  at  high 
stimulator-cell concentrations (4 ×  105 TeII cells/microtiter well). Only with decreas- 
ing cell concentrations did lymphocyte proliferation occur. The peak of the stimulation 
was  reached with  1 ×  10  s autologous TeII cells per well, indicating a  stimulation 
index of 2.4. A similar reaction pattern was observed with allogeneic TeII stimulators, 830  LYMPHOCYTE REACTIVITY AGAINST TESTICULAR CELLS 
except that  the stimulation  peak with  1 X  10  ~ cells per well was  higher than with 
autologous TeII stimulators (stimulation index: 5.4). 
In experiments testing lymphocyte reactivity against  the TeI fraction, we found 
that autologous TeI cells did induce stimulation in the responder cells (Fig.  1). This 
phenomenon is limited to testicular cells because autologous irradiated spleen cells 
failed to induce lymphocyte proliferation. The reactivity against autologous TeI cells 
was dose dependent; the peak of the response was reached with 2 ×  105 TeI cells per 
well with a stimulation index of 3.6.  In contrast to autologous TeII cells, stimulation 
against  the TeI fraction was 46% higher at this cell concentration (P <  0.01). With 
increasing stimulator cell concentrations (4 ×  105 cells per well) lymphocyte prolifer- 
ation  decreased.  This might  be a  result  of contaminating  germ  cells derived from 
broken  tubules  during  the  cell  preparation  that  may  have  inhibitory  effects  on 
lymphocyte proliferation. In addition to thymidine uptake, stimulation was monitored 
by the counting of blasts. Approximately 10% more blasts were detected in cultures 
stimulated at the optimal TeI concentration than in unstimulated controls. 
As  expected,  allogeneic  TeI  cells  did  stimulate  lymphocyte  proliferation.  The 
reactivity against these cells was similar to the activity against autologous TeI cells in 
terms  of the  peak  of the  response  and  the  decrease  with  higher  stimulator  cell 
concentration. The peak of the stimulation was reached with 2  ×  105 cells per well 
(stimulation index:  6.1);  at this concentration the reactivity was  -66% higher than 
against allogeneic TeII cells (P <  0.01). However, alloreactivity against TeI ceils was 
much lower than against spleen cells (Fig.  1). 
It  has  been shown  that  autoantigens are sometimes revealed by treatment  with 
various kinds of proteases (13). We tested for this possibility by measuring lymphocyte 
reactivity to mechanically fractionated testicular cells compared to protease-treated 
stimulators. Table I shows that testicular cells released by either mechanical treatment 
or  protease  treatment  induce  comparable  effects.  The  higher  stimulation  against 
protease-treated testicular cells, observed in some experiments, was probably a result 
of the better viability of cells prepared by this more gentle treatment. 
Suppression  of Autologous  and  Allogeneic  Immune  Response  with  Autologous  Testicular 
Cells.  The unexpected low reactivity of spleen cells against  the autologous seques- 
tered testicular cell fraction could obviously result either from a  failure of TeII cells 
to stimulate or from their ability to induce active suppression. The second possibility 
seemed the more likely, because the proliferative response increased with decreasing 
cell concentration. To test this, autologous TeII cells were cocuhivated with stimula- 
tors known to be capable of inducing lymphocyte proliferation; e.g., autologous and 
allogeneic TeI cells, and allogeneic spleen cells.  The results are depicted in Tables II 
and  III. The response against  autologous and  allogeneic TeI cells was significantly 
decreased in the presence of autologous TeII cells, with lymphocyte proliferation in 
both cases reduced by 64% (P <  0.01) (Table II). It can be excluded that cell density 
effects caused the reduction of the responder cell proliferation, doubling the stimulator 
concentration by cocuhuring of TeI plus TeII cells (final stimulator concentration = 
4 ×  105 cells/well). With the same cell concentration (4 ×  105 cells/well) proliferation 
against  autologous TeI cells is 55% and  against  allogeneic TeI cells is 63% higher. 
Stimulation against  allogeneic spleen cells was even more strongly depressed, to as 
little as  10% of controls (Table III). The suppressive effect of autologous TeII cells 
was clearly dependent on the cell concentration. Autologous TeI cells did not affect 
allogeneic spleen cell responses (Table III). U.  HURTENBAGH,  F.  MORGENSTERN,  AND  D.  BENNETT 
TABLE  I 
Stimulation against Protease-treated  or Mechanically Treated Testicular Cells 
83t 
Experi- 
ment  Responders  Stimulators* 
Protease treated  Mechanically treated 
cpm ±  SD  SI~  cpm ±  SD  SI 
B6 spleen cells  --  575 --- 109  463 +  134 
B6 spleen cells  B6 TeI  2,181 ±  536  3.7  1,006 ±  96  2.1 
B6 spleen cells  B6 TeII  8t2 ±  89  1.4  446 +  108  0.9 
B6 spleen cells  A/J TeI  1,245 ±  302  2.1  1,723 ±  391  3.7 
B6 spleen cells  A/J TeII  534 ±  212  0.9  364 ±  51  0.8 
A/J spleen cells  --  401 ±  21  488 ±  71 
A/J spleen cells  A/J TeI  1,542 ±  116  3.8  1,344 _  158  2.7 
A/J spleen cells  A/J TeII  500 ±  134  1.2  233 ±  86  0.5 
A/J spleen cells  B6 Tel  2,084 -  356  5.1  1,373 ±  179  2.8 
A/J spleen cells  B6 TeII  938 ±  375  2.3  257 ± 84  0.5 
* 2 ×  105 stimulators/well. 
:1: SI, stimulation index. 
TABLE  II 
Cocultivation of Autologous and Allogeneic Tel Cells with Autologous TelI Cells 
Responders  Stimulators  cpm ±  SD  SI 
B6 spleen cells  --  615 ±  35 
B6 spleen cells  B6 spleen cells*  653 +  70  1.07 
B6 spleen cells  B6 TeI (4 ×  105)  1,562 ±  141  2.53 
B6 spleen cells  B6 TeI (2 ×  105)  1,896 +  270  3.08 
B6 spleen cells  B6 TeII (2 ×  105)  993 ±  160  1.61 
B6 spleen cells  B6 TeI (2 ×  105) +  B6  700 +  52  1.13 
TeII (2 X  105) 
B6 spleen cells  CBA spleen cells*  9,366 + 476  15.22 
B6 spleen ceils  CBA TeI (4 ×  105)  2,239 ±  234  3.64 
B6 spleen cells  CBA TeI (2 ×  105)  2,260 +  464  3.67 
B6 spleen cells  CBA TeII (2 ×  10  r)  677 ±  131  1.10 
B6 spleen cells  CBA TeI (2 ×  105) +  832 +  42  1.35 
B6 TelI (2 ×  105) 
* 5 ×  105 spleen cells/well. 
Nature of  the Responder Cells.  As shown in Tables II and III, lymphocyte  proliferation 
is suppressed  in the presence of autologous  and  allogeneic TeII  cells. To characterize 
the lymphoid  cell type responsible for the suppression associated with autologous TeII 
cells,  physical  and  serological  separation  methods  were  used.  Table  IV  summarizes 
the response of spleen cells depleted  of B  cells and  adherent  macrophages  by passage 
over a  nylon-wool  column.  Reactivity  against autologous  and  allogeneic TeII  cells is 
not  changed  significantly,  which  suggests  that  macrophages  can  be  excluded  as 
significant inhibitors of lymphocyte  proliferation  (14). 
In a  further analysis of the origin of suppressor activity, spleen cells were pretreated 
with anti-Ly-2.2  antibody  plus complement  to eliminate  suppressor T  cells.  Table  V 832  LYMPHOCYTE  REACTIVITY  AGAINST TESTICULAR  CELLS 
TABLE  III 
Cocultivation of Autologous TeI and TelI Cells with Allogeneic Spleen Cells 
Responders  Stimulators  cpm ±  SD  SI 
B6 spleen cells 
B6 spleen cells  B6 spleen cells 
B6 spleen cells  A/J spleen cells 
B6 spleen cells  B6 TeI (4 X  10  5) 
B6 spleen cells  B6 TeI (2 ×  l0  s) 
B6 spleen cells  A/J spleen cells +  B6 Tel 
(4 ×  10  r') 
B6 spleen cells  A/J spleen cells +  B6 Tel 
(2 X 105) 
B6 spleen cells  B6 TelI (4 ×  10  5) 
B6 spleen cells  B6 TeII (2 ×  10  r') 
B6 spleen ceils  B6 TelI (1 ×  105) 
B6 spleen cells  B6 TelI (0.5 x  105) 
B6 spleen cells  A/J spleen  cells  +  B6 TeII 
(4 X  10  5) 
B6 spleen cells  A/J spleen  cells  +  B6 TeII 
(2 x  1o  ~) 
B6 spleen cells  A/J spleen  cells  +  B6 TelI 
(1  x  10 s) 
B6 spleen cells  A/J  spleen  ceils  +  B6 TeII 
(0.5 x  105) 
364 ±  136 
454 ±  157  1.2 
13,500 ±  509  37.0 
1,026 ± 88  2.8 
1,602 ±  101  4.4 
14,725 ±  1,392  40.4 
14,677 ±  669  40.3 
460 ±  64  1.2 
620 ±  58  1.7 
1,228 ±  241  3.3 
591 ± 95  1.6 
949 ±  113  2.6 
1,240 ±  151  3.4 
12,799± 1,113  35.7 
l 1,174 ±  1,058  30.6 
TABLE  IV 
Enrichment of T Cells by Nylon- Wool Passage 
Responders  Stimulators 
Untreated  T cell enriched 
cpm ±  SD  SI  cpm ±  SD  SI 
B6 spleen cells  --  426 ±  43  553 ±  17 
B6 spleen cells  B6 TeI  1,563 ±  385  3.6  2,640:1:586  4.8 
B6 spleen cells  B6 TeII  640 ±  156  1.5  765 ±  24  1.3 
B6 spleen cells  AKR spleen cells  6,390 +  360  15.0  9,936 ±  226  17.9 
B6 spleen cells  AKR TeI  4,188 ± 450  9.8  7,242 +  514  13.0 
B6 spleen cells  AKR TeII  2,109 ±  388  4.9  3,201 +  558  5.8 
shows that such elimination  results in a  normal  allogeneic spleen cell response, as well 
as reactivity against autologous TeI cells. Moreover,  the reactivity against autologous 
TeII  cells alone reached  the same  level as the response against TeI  cells. These  data 
indicate that  immunosuppression  in the presence of autologous  TeII  cells is induced 
by suppressor T  cells. 
Also demonstrated  in Table  IV is the proliferative response against autologous and 
allogeneic TeI cells after depletion of B  cells and  adherent  macrophages.  Because the 
reactivity is still maintained,  B  cells are unlikely to be involved in response. To  define U.  HURTENBACH,  F.  MORGENSTERN,  AND D.  BENNETT 
TABLE V 
Pretreatment of Responder Cells with Ly-2.2 Antiserum +  Complement 
833 
Responders  Stimulators 
Untreated 
cpm ± SD  SI 
Anti-Ly-2.2 + comple- 
ment-treated 
cpm :!: SD  SI 
B6 spleen cells  --  1,710 ± 68 
B6 spleen cells  B6 TeI  6,2t 7 ± 563  3.63 
B6 spleen cells  B6 TeII  3,023 ± 708  1.76 
B6 spleen ceils  B6 TeI+ B6 Tell  1,245 ± 229  0.72 
B6 spleen cells  BALB/c  spleen cells  19,585 ±  1,845  11.45 
B6 spleen cells  BALB/c  spleen cells  6,052 ± 727  3.53 
+  B6 TeII 
1,102 ± 644 
8,797 ± 579  7.98 
12,511 ±  1,524  11.35 
7,171 :::lz  640  6.50 
20,459 ±  1,766  18.56 
19,497± 1,900  17.69 
TABLE  VI 
Pretreatment of Responder Cells with Thy-l.2 Antiserum +  Complement 
Responders  Stimulators 
Untreated  Anti-Thy- 1.2 + comple- 
ment-treated 
cpm ± SD  SI  cpm ± SD  SI 
B6 spleen cells  --  770 ± 84  1,008 ±  154 
B6 spleen cells  B6 TeI  4,532 ±  1,169  5.88  1,808 ± 564  1.80 
B6 spleen cells  B6 TeII  840 ±  131  1.09  2,040 3= 361  2.04 
B6 spleen cells  A/J spleen cells  34,052 ± 10,210  44.2  1,167 ± 255  1.16 
B6 spleen cells  A/J TeI  14,143 ± 2,576  t8.2  7,695 +  1,031  7.69 
B6 spleen cells  A/J TeII  2,517 ± 1,357  3.2  859 ± 454  0.85 
B6 spleen cells  PHA  30,096 + 3,516  39.08  2,003:1:427  2.00 
whether T  cells were proliferating, spleen cells were pretreated with monoclonal anti- 
Thy-l.2  antibody plus  complement.  Table  VI  shows  that  elimination of T  cells 
significantly reduced stimulation (P <  0.01)  but does not abolish it completely. As 
expected, the response against allogeneic spleen cells is totally abrogated.  Likewise, 
the  mitogenic response  against  PHA  is  reduced  by 91%.  This  data  indicate that, 
besides T  cells, other lymphoid ceils respond on stimulation by fraction TeI cells. 
Nature  of the  Testicular Cell Population Inducing Suppressor T  Cell Activity.  Further 
experiments were undertaken to confirm that the cells responsible for suppressor T 
cell induction were, in fact, germ cells within the TeII fraction. We took advantage of 
the fact that mutations at the W  and W v locus produce heterozygotes that are sterile. 
W/W v compound males have normally developed somatic components of the testis 
but almost no germ cells (15). Thus, in these males the TeI population is comparable 
to that  of wild-type animals, but the TeII fraction contains essentially only Sertoli 
cells. The responder lymphocytes were derived from wild-type siblings of Fa W/W v 
animals. Table VII shows that syngeneic TeI and TeII cells of W/W v mice evoked a 
strong lymphocyte stimulation which even exceeded the reactivity against allogeneic 
spleen  cells.  Moreover,  W/W ~  TeII  cells  did  not  suppress  the  response  against 
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TABLE  VII 
Stimulation against Germ-Cell-depleted Testicular Cells 
Responders  Stimulators  cpm ±  SD  SI 
(+/+)  spleen cells  --  550 ±  53 
(+/+)  spleen cells  (+/+) Tel  3,668 ±  440  6.66 
(+/+)  spleen cells  (+/+)  TeII  1,533 ±  255  2.78 
(+/+)  spleen cells  W/W v spleen cells  572 ±  55  1.04 
(+/+)  spleen cells  W/W v TeI  16,963 ±  1,093  30~84 
(+/+)  spleen cells  W/W v TelI  16,450 +  2,993  29.90 
(+/+)  spleen cells  B6 H-2  k spleen cells  13,528 +  1,664  24.10 
(+/+) spleen cells  B6 H-2  k TeI  5,~;27 ±  128  10.23 
(+/+) spleen cells  B6 H-2  k TeII  2,670 +  420  4.85 
(+/+)  spleen cells  B6 H-2  k spleen cells +  (+/+)  TeII  1,598 +  172  2.90 
(+/+)  spleen cells  B6 H-2 k spleen cells +  W/W v TeI  13,618 ±  2,822  24.76 
(+/+) spleen cells  B6 H-2  k spleen cells +  W/W v TelI  13,270 ±  2,806  24.2 
Discussion 
These experiments  describe lymphocyte reactivity in vitro against  autologous and 
allogeneic  testicular  cells  in  the  presence  of  autologous  serum.  We  investigated 
lymphocyte reactivity against autoantigens  on testicular cells derived from the semi- 
niferous  tubules  that  normally  are  not  accessible to  the  immune  system,  and  thus 
should be expected to be autoantigenic.  This cell population  contained  Sertoli cells 
and  germ  cells  (TeII).  As controls,  we tested  reactivity  against  cells  deriving  from 
non-immunoiogically  privileged sites in the testis, a  fraction  containing  Leydig and 
other interstitial cells (TeI). These experiments revealed two contrary and unexpected 
findings:  (a)  somatic cells of the testes deriving  from nonprivileged  sites stimulated 
lymphocyte proliferation;  (b) germ cells deriving from the immunologically privileged 
site suppressed lymphocyte prolifer~.tion. 
The reactive lymphocytes Were primarily T  cells. The proliferative response to TeI 
cells  was  not'altered  by  elimination  of B  cells  and  adherent  'macrophages  from 
responder  p0pulations,  whereas'stimulati0n  Wasi'considerably~reduced  when  only T 
cells were removed by complement-depen'dent  lysis with  anti-Thy-l.2  serum.  How- 
ever, lymphocyte reactivity was not completely iabolished in this case, indicating  that 
part  of the responder  population  ,~as  resistant  to  anti-Thy-l.2  plus  complement 
treatment.  Several  explanations  for  this  observation,  are  possibl e.  It  is  likely  that 
treatment  with anti-Thy-l.2  antibod f  plus complement  generally  depletes, but does 
not eliminate, the entire T  cell populatiqn,  It may also be that  the specific types ofT 
ce!ls  i that react against test'icular Cells express relat!ve!y'low concentra'tions of Thy-i.2 
antigen and are, thus, relatively insensitive to lysis. It has been Shown in fact that Ly- 
1,2,3 + cells, which ' are precursors'of helPer and suppressor T  cells, are resistant  to a 
single treatment  with anti-Thy-l.2  plus complement  (16); it is thus possible that such 
cells escaped elimination  and thus differentiated toLy-1 + cells (helper-T cells) during 
the  5  d  of in  vitro  incubation.  Furthermore,  i( cannot  be  excluded  that  another 
lymlShoid cell population  is involved, such as natural-killer  cells (17). 
The interstitial  cell population  of normal  mice (TeI) provided significant  stimula- U. HURTENBACH, F.  MORGENSTERN, AND D.  BENNETT  835 
tion, and populations of syngeneic somatic cells, interstitial cells or Sertoli cells from 
germ-cell depleted W/W  v mice, produced several  fold stronger proliferation of the 
responding lymphocytes. Also, TeII  fractions that  contained germ cells stimulated 
lymphocyte proliferation after elimination of suppressor T  cells (see below). Theoret- 
ically  there  are  several  possibilities  for  lymphocyte stimulation.  Collagenase  and 
trypsin were used to prepare the two testicular cell fractions, and, therefore, protease 
treatment could have exposed normally hidden autoantigen or modified self antigens 
(5,  6,  13).  However,  mechanically  prepared  testicular  cells  induced  comparable 
lymphocyte proliferation. Thus, the probability of exposure or artificial alterations of 
cell-surface antigens seems rather unlikely. Modulation of the immune response by 
sex hormones has been reported by various authors (18-20), and because Leydig cells 
produce testosterone, the question arose whether the stimulation against cells of TeI 
fraction was elicited by secreted hormone in the culture supernate, or by hormonal 
modification of self antigen on the testicular cells themselves. The observation that 
androgen decreases autoimmune reactions in NZB/W mice (21), and thus is immu- 
nosuppressive, makes this possibility less  likely. Another possible explanation is the 
expression  of viral  antigens  on  testicular  cells.  Various  reports  demonstrate  the 
spontaneous appearance of endogenous virus products after in vitro cultivation (22- 
24). Furthermore, immunofluorescence techniques have revealed gp70 in the epithe- 
lium  of the  epididymis  and  vas  deferens,  with  quantitative  differences in  various 
mouse  strains  (25).  However, gp70  has  never been  identified  in  the  testis.  These 
observations, in addition to our finding that  autologous spleen cell stimulators are 
incapable of inducing proliferation, lower the possibility of viral infection as the cause 
of the antigenicity of autologous TeI cells, but certainly does not exclude this. 
The antigenic determinants responsible for lymphocyte stimulation against autol- 
ogous testicular cells are not yet identified.  Recently, the recognition of self major 
histocompatibility complex (MHC)  antigens has been shown to be essential for the 
response against  foreign antigens.  This  has been  demonstrated  in  T  cell responses 
against chemically modified cells (26), virus-infected target cells (27), weak histocom- 
patibility antigens (28), and male-specific H-Y antigen (29).  Moreover, the immuno- 
logical memory and specificity of rat lymphocytes against syngeneic (somatic) testic- 
ular cells which has been demonstrated in vitro, was strongly restricted to self MHC 
antigens, and to tissue-specific antigens  (30). The Ia antigens of the H-2 system are 
known  to  have  a  restricted  tissue  distribution  (31).  Although  the  presence  of Ia 
antigens on testicular somatic cells has not been shown so far, it has been demonstrated 
on spermatocytes  (32)  and  sperm  (31).  Thus,  it  can  be suggested  that  stimulation 
against  autologous testicular cells is caused  by recognition of self MHC  antigen(s) 
and testicular-cell antigen(s). Questions concerning the specificity of the stimulation 
are now under study. 
The lymphocyte proliferation induced by autologous somatic testicular cells con- 
trasts strongly with the suppression induced by germ cells of the same animals. This 
immune suppression can be abrogated by anti-Ly-2.2 plus complement treatment of 
the responder cells and  thus is a  result of the activation of suppressor T  cells. The 
target activity of the suppressor cells seems to be nonspecific, because they are capable 
of inhibiting lymphocyte proliferation against  syngeneic TeI cells as well as against 
allogeneic spleen cells. The degree of stimulation or suppression apparently depends 
very delicately on  the relative  proportions of germ  cells  in  the  two  testicular  cell 836  LYMPHOCYTE REACTIVITY AGAINST TESTICULAR CELLS 
fractions; that is, on the number of cells in each population that are able to induce 
suppressor T  cell activity. Increasing concentrations of TeI cells lead to a decrease in 
stimulation, presumably because the number of contaminating germ cells is increased, 
whereas low concentrations of TeII cells or pure Sertoli cells (fraction TeII of W/W  v 
mice) resulted in an increased proliferative response. 
The determinants on the germ cells responsible for the induction of suppressor cells 
have not been identified either. However, it has been shown that germ cells express 
embryonic  antigens  (33),  and  furthermore,  many  reports  demonstrate  suppressor 
functions  of embryonic  cells  or  embryonic  antigens;  e.g.,  embryonic  hepatocytes 
suppress graft-versus-host and mixed-leukocyte responses (34), and human or murine 
a-fetoprotein regulates the induction of suppressor cells (35, 36). 
Our observations suggest that germ cells have similar immunoregulatory functions 
which may operate via embryonic antigens.  Under normal in vivo conditions, germ 
cells are  segregated  from the body by the  blood-testis barrier which  preserves the 
microenvironment of the developing spermatozoa and ensures their isolation (37). In 
the event the blood-testis barrier is inoperative; e.g., by physical injury or inflamma- 
tion, germ cells may prevent autoimmune reactions by the induction of suppressor T 
cells which  generate  immunological  protection.  Similarly,  embryonic antigens  ex- 
pressed on early mouse embryos (38) may be responsible for immunological protection 
of the fetus from the maternal immune system in early stages of pregnancy. 
Summary 
We  have  investigated  the  regulation  of self tolerance  in  mice  by  examining 
lymphocyte reactivity in  vitro against  two subpopulations  of autologous  testicular 
cells:  germ  cells  that  were  derived  from  the  seminiferous tubules,  and  interstitial 
somatic cells.  In  the presence of germ  cells,  lymphocyte proliferation was  strongly 
reduced. In contrast, somatic interstitial cells stimulated lymphocyte proliferation. In 
both cases, reactive lymphocytes were mostly T  cells.  Suppressor T  cells activated by 
autologous germ cells were nonspecific and capable of inhibiting lymphocyte prolif- 
eration against  autologous and  allogeneic somatic testicular cells as well as against 
allogeneic spleen cells.  Suppression was abrogated after treatment of the responder 
lymphocytes with anti-Ly-2.2 serum plus complement. Lymphocyte proliferation by 
autologous interstitial cells was considerably reduced, but not completely abolished, 
by  complement-dependent  lysis  with  anti-Thy-l.2  serum.  This  may  indicate  the 
participation in proliferation of a lymphoid cell population other than T  cells. 
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